Oltmans Curtis Gale - Insider Non-Derivative Transactions at Fulcrum Therapeutics, Inc. (FULC) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 15, 2025, Oltmans Curtis Gale's relationship to Fulcrum Therapeutics, Inc. (FULC) is Officer (Chief Legal Officer), and currently has 10,252 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other FULC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Oltmans Curtis Gale - Insider Non-Derivative Transactions of FULC Common Stock

Oltmans Curtis Gale - Insider Non-Derivative Transactions at FULC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 16, 2025	Sell -- (Common Stock)	3452	12.92	10252